"飲み込むのは難しい薬" クロルプロマジンによるプリアピズムのケースシリーズ
Matthew Kwon1, Kathleen Lockhart1, Hugh Reid2
1Department of Urology, John Hunter Hospital, New Lambton Heights, NSW 2305, Australia.
The Canadian journal of urology
|September 5, 2025
まとめ
偏頭痛に使用されるクロプロマジンの珍しい副作用であるプリアピズムは勃起不全を引き起こす可能性があります. この深刻な合併症の管理には,迅速な治療が不可欠です.
科学分野:
- 神経学
- 薬理学について
- 泌尿器科
背景:
- クロロプロマジンは,耐火性片頭痛の治療に頻繁に使用されます.
- プリアピズムは 認知されているが あまり報告されていない 特定の薬の副作用です
- 低血圧性プリアピズムは重篤で永久的な勃起不全を引き起こす可能性があります.
研究 の 目的:
- 片頭痛に対するクロロプロマジンの静脈内投与後に発症した3症例を報告する.
- クロロプロマジンとプリアピズムとの関連を強調する
- この有害事象の迅速な診断と管理の重要性を強調する.
主な方法:
- 3人の男性患者を記述したケースシリーズです
- 片頭痛に対するクロロプロマジンの静脈内投与後の臨床表現と治療のレビュー
- プリアピズム管理に関する結果の分析
主要な成果:
- 3人の男性は,片頭痛のために静脈内クロルプロマジンを受けた後,血性プリアピズムを発症しました.
- プリアピズムの認識と管理の遅延
- プリアピズムによる長期的な勃起不全の可能性
結論:
- 静脈内クロルプロマジンは,片頭痛の患者で血性プリアピズムを発生させる可能性があります.
- 臨床医は,この有害な効果を高い確率で疑う必要があります.
- 永久性勃起不全を予防するには,緊急の医療評価と治療が不可欠です.
関連する概念動画
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
533
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
533
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
973
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
973
Anticholinesterase Agents: Poisoning and Treatment
1.1K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.1K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
489
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
489
Parkinson's Disease: Treatment
441
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
441
Depolarizing Blockers: Pharmocokinetics
406
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
406


